• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NanoViricides, Inc. Common Stock (NY:NNVC)

0.9263 -0.0299 (-3.13%)
Official Closing Price Updated: 6:30 PM EST, Mar 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NanoViricides, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
June 14, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
June 12, 2024
 
Via Benzinga
News headline image
Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral Effect
June 11, 2024
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
June 10, 2024
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
June 06, 2024
Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news affecting shares this morning! 
Via InvestorPlace
News headline image
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for Strong Antiviral Effect
June 04, 2024
Via ACCESSWIRE
News headline image
A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More
May 29, 2024
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
June 05, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
June 04, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
June 03, 2024
 
Via Benzinga
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results
May 29, 2024
Via AB Newswire
News headline image
Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure
May 20, 2024
Via ACCESSWIRE
News headline image
NanoViricides Has Filed its Quarterly Report
May 15, 2024
Via ACCESSWIRE
News headline image
A Novel Broad-Spectrum Antiviral with Activity Against RSV
May 14, 2024
Via ACCESSWIRE
News headline image
A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
May 08, 2024
Via ACCESSWIRE
News headline image
NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.
May 23, 2024
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
May 16, 2024
 
Via Benzinga
News headline image
NNVC Stock Earnings: Nanoviricides Beats EPS for Q3 2024 ↗
May 15, 2024
NNVC stock results show that Nanoviricides beat analyst estimates for earnings per share the third quarter of 2024. 
Via InvestorPlace
News headline image
NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York City
May 10, 2024
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
May 06, 2024
 
Via Benzinga
News headline image
A Novel Broad-Spectrum Antiviral with Activity Against Influenza A
May 06, 2024
Via ACCESSWIRE
News headline image
3 Nanotech Stocks With the Potential to Make You an Overnight Millionaire ↗
May 02, 2024
Discover three nanotech stocks poised for explosive growth in a booming market. Explore their potential for massive returns. 
Via InvestorPlace
News headline image
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
April 30, 2024
Via ACCESSWIRE
News headline image
NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizon
February 15, 2024
Via ACCESSWIRE
News headline image
Clinical Trial Demonstration of Safety and Tolerability of NV-CoV-2 Has Implications Beyond COVID Treatment, Explains NanoViricides - NV-387 Could be As Revolutionary as Antibiotics
February 01, 2024
Via ACCESSWIRE
News headline image
A New COVID-19 Variant Is Rapidly Spreading Around The Globe, Other Pandemic Threats Exist – What Are The Choices For Treatment? ↗
January 31, 2024
Colds, flu and RSV aren't the only viral illnesses people have to worry about this winter. A new variant of COVID-19 is rapidly spreading, reminding the world of just how dangerous this virus is. 
Via Benzinga
News headline image
Safety in Multiple-Ascending-Dose Healthy Subjects Clinical Trial Part Successfully Established for the NanoViricides Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2 with No Adverse Events Found
January 29, 2024
Via ACCESSWIRE
News headline image
NanoViricides, Inc. (NNVC) To Unveil Cutting-Edge Antiviral Breakthroughs At Biotech Showcase™ 2024 ↗
January 08, 2024
NanoViricides, Inc. (NYSE American: NNVC) recently announced that it is presenting at Biotech Showcase™ 2024. Event Information: Event NanoViricides Presentation at the Biotech Showcase, San Fransisco 
Via Benzinga
News headline image
NanoViricides to Present at the Biotech Showcase in San Fransisco
January 04, 2024
Via ACCESSWIRE
Is This Ticker That InvestorsObserver Expects To Soar By More Than 350% Next Year On Your Watchlist?
December 01, 2023
--News Direct-- 
Via News Direct
Topics Death
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap